Dr. Matthew “Tex” VerMilyea, PhD, HCLD/CC is Vice President of Scientific Advancement at US Fertility, where he serves as a scientific resource and operational advocate for the network’s IVF laboratories nationwide. He guides the adoption of new technologies and research across the network, coordinates collaboration among laboratory teams, and evaluates procedures and outcomes to establish best practices.

Dr. VerMilyea leads multi-center research on artificial intelligence in IVF, including award-nominated work on AI-based assessment of embryo viability, and has presented comparative AI and embryologist findings globally. Previously at Ovation Fertility, he served as Vice President of IVF Lab Operations for the network and as Laboratory Director for multiple IVF laboratories.

Earlier in his career, he completed postdoctoral fellowships at the Institute of Biomedical Research in Birmingham, UK, and, as a Japan Society for the Promotion of Science fellow, at the RIKEN Institute in Kobe, Japan. He has held academic appointments at the University of Pennsylvania, Victoria University of Wellington, and the University of Auckland, and is board certified as a High-Complexity Clinical Laboratory Director and Clinical Consultant.

Education: BS, Cornell University; PhD in Genetics, University of Birmingham (UK).